Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | C1R | P00736 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL701527 | 0.76 | TSHR (0.46) | ALDH1A1TDP1L3MBTL1MGAMGAA | |
| SCHEMBL30315779 | 0.76 | TSHR (0.46) | ALDH1A1TDP1L3MBTL1MGAMGAA | |
| SCHEMBL10547950 | 0.73 | CRBN (0.47) | CRBNALDH1A1TDP1L3MBTL1MGAM | |
| SCHEMBL30535903 | 0.72 | ALDH1A1 (0.74) | ALDH1A1TDP1L3MBTL1MGAMGAA | |
| SCHEMBL1287837 | 0.72 | ALDH1A1 (0.74) | ALDH1A1TDP1L3MBTL1MGAMGAA | |
| SCHEMBL8993582 | 0.71 | ALDH1A1 (0.61) | ALDH1A1TDP1L3MBTL1MGAMGAA | |
| SCHEMBL6773844 | 0.71 | ALDH1A1 (0.47) | CRBNALDH1A1TDP1L3MBTL1MGAM | |
| SCHEMBL3175492 | 0.70 | HPGD (0.44) | ALDH1A1L3MBTL1KMT2AMAPTNPC1 | |
| SCHEMBL8626370 | 0.70 | CRBN (0.41) | CRBNALDH1A1TDP1L3MBTL1GAA | |
| SCHEMBL30987815 | 0.70 | ALDH1A1 (0.71) | ALDH1A1TDP1L3MBTL1MGAMGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9439432-B2 | Phenylisoxazoline-based compound having herbicidal activity and use thereof | MOGHU RESEARCH CENTER LTD (KR) | 2016-09-13 | — | — | US | disclosed |
| EP-2765129-B1 | PHENYLISOXAZOLINE COMPOUND HAVING HERBICIDAL PROPERTIES AND USE THEREOF | KOREA RES INST CHEM TECH (KR) | 2016-04-06 | — | — | EP | disclosed |
| US-20140256553-A1 | PHENYLISOXAZOLINE-BASED COMPOUND HAVING HERBICIDAL ACTIVITY AND USE THEREOF | MOGHU RESEARCH CENTER LTD. (KR) | 2014-09-11 | — | — | US | disclosed |
| EP-2765129-A1 | PHENYLISOXAZOLINE COMPOUND HAVING HERBICIDAL PROPERTIES AND USE THEREOF | Korea Research Institute of Chemical Technology (KR) | 2014-08-13 | — | — | EP | disclosed |
| US-5262388-A | Isooxazoline ethers | SHELL RESEARCH LIMITED (GB) | 1993-11-16 | — | — | US | disclosed |
| EP-0514987-A1 | Herbicidal compounds | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1992-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256553-A1 | PHENYLISOXAZOLINE-BASED COMPOUND HAVING HERBICIDAL ACTIVITY AND USE THEREOF | CYP4X1, HPD, NOTUM | CRBN 4174/4885ALDH1A1 590/4885TDP1 2577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.